Exact Mass: 723.2783

Exact Mass Matches: 723.2783

Found 29 metabolites which its exact mass value is equals to given mass value 723.2783, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Trypanothione

(2S)-2-amino-4-{[(1R)-1-{[({3-[(4-{2-[(2R)-2-[(4S)-4-amino-4-carboxybutanamido]-3-sulfanylpropanamido]acetamido}butyl)amino]propyl}carbamoyl)methyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C27H49N9O10S2 (723.3044)


Leishmaniasis is a neglected disease caused by Leishmania, an intracellular protozoan parasite which possesses a unique thiol metabolism based on trypanothione. (PMID: 22928053) Trypanosomatids, the causative agents of several tropical diseases, rely on trypanothione as principal low molecular mass thiol, and their glutaredoxins readily react with the unique bis(glutathionyl) spermidine conjugate. (PMID: 22978520) Among the potential molecular target, Trypanothione reductase (TR) is considered an ideal enzyme since it is involved in the unique thiol-based metabolism observed in the Trypanosomatidae family and is a validated target for the search of antitrypanosomatidae drugs. (PMID: 23410156)

   
   
   

Phe Trp Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C42H41N7O5 (723.3169)


   

Trp Phe Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C42H41N7O5 (723.3169)


   

Trp Trp Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C42H41N7O5 (723.3169)


   

Trp Trp Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C42H41N7O5 (723.3169)


   

4,5-BENZO-1-ETHYL-3,3,3,3-TETRAMETHYL-1-(4-SULFOBUTYL)INDODICARBOCYANIN-5-ACETIC ACID N-SUCCINIMIDYL ESTER

4,5-BENZO-1-ETHYL-3,3,3,3-TETRAMETHYL-1-(4-SULFOBUTYL)INDODICARBOCYANIN-5-ACETIC ACID N-SUCCINIMIDYL ESTER

C41H45N3O7S (723.2978)


   

Chloro[[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene](N,N-dimethyl-3,5-dimethoxybenzylamine)palladium(II)]

Chloro[[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene](N,N-dimethyl-3,5-dimethoxybenzylamine)palladium(II)]

C38H52ClN3O2Pd (723.2783)


   

8-chloro-11-[1-[[5-[[4-(8-chloro-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridin-11-ylidene)piperidin-1-yl]methyl]pyridin-3-yl]methyl]piperidin-4-ylidene]-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridine

8-chloro-11-[1-[[5-[[4-(8-chloro-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridin-11-ylidene)piperidin-1-yl]methyl]pyridin-3-yl]methyl]piperidin-4-ylidene]-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridine

C45H43Cl2N5 (723.2895)


   

Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH

Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH

C44H41N3O7 (723.2944)


   

Rendix

Dabigatran etexilate mesylate

C35H45N7O8S (723.305)


C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins

   

ethoxazorutoside

ethoxazorutoside

C33H41NO17 (723.2374)


   
   

N-[(3S,9S,10S)-9-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide

N-[(3S,9S,10S)-9-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide

C35H44Cl2FN3O6S (723.2312)


   

4-fluoro-N-[(3S,9S,10S)-9-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide

4-fluoro-N-[(3S,9S,10S)-9-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide

C34H43F2N3O8S2 (723.246)


   

N-[(3R,9S,10S)-9-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide

N-[(3R,9S,10S)-9-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide

C35H44Cl2FN3O6S (723.2312)


   

N-[(3S,9R,10R)-9-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide

N-[(3S,9R,10R)-9-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide

C35H44Cl2FN3O6S (723.2312)


   

2-aminoethyl alpha-D-glucopyranosyl-(1->4)-alpha-D-galactopyranosyl-(1->4)-beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranoside

2-aminoethyl alpha-D-glucopyranosyl-(1->4)-alpha-D-galactopyranosyl-(1->4)-beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranoside

C26H45NO22 (723.2433)


   

2-aminoethyl beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-alpha-D-galactopyranoside

2-aminoethyl beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-alpha-D-galactopyranoside

C26H45NO22 (723.2433)


   

BIS(GAMMA-glutamyl-cysteinyl-glycinyl)spermidine

BIS(GAMMA-glutamyl-cysteinyl-glycinyl)spermidine

C27H49N9O10S2 (723.3044)


   

Dabigatran etexilate mesylate

Dabigatran etexilate mesylate

C35H45N7O8S (723.305)


C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins

   
   
   

(2s)-2-{[(3s)-3-({[(1s)-3-(5-{[(5s)-5-(3-carbamimidamidopropyl)-6-hydroxy-3-oxo-4,5-dihydropyrazin-2-ylidene]methyl}-2-hydroxyphenoxy)-1-carboxypropyl]-c-hydroxycarbonimidoyl}methyl)-3-carboxy-1,3-dihydroxypropylidene]amino}butanedioic acid

(2s)-2-{[(3s)-3-({[(1s)-3-(5-{[(5s)-5-(3-carbamimidamidopropyl)-6-hydroxy-3-oxo-4,5-dihydropyrazin-2-ylidene]methyl}-2-hydroxyphenoxy)-1-carboxypropyl]-c-hydroxycarbonimidoyl}methyl)-3-carboxy-1,3-dihydroxypropylidene]amino}butanedioic acid

C29H37N7O15 (723.2348)


   

8-benzyl-10,17,24-trihydroxy-26-methyl-15,22-bis(sec-butyl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,14(30),16,21(29),23-hexaen-7-one

8-benzyl-10,17,24-trihydroxy-26-methyl-15,22-bis(sec-butyl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,14(30),16,21(29),23-hexaen-7-one

C36H49N7O5S2 (723.3236)


   

(2r,8s,11s,15s,18s,22s,25s,26r)-8-benzyl-22-[(2r)-butan-2-yl]-15-[(2s)-butan-2-yl]-10,17,24-trihydroxy-26-methyl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,14(30),16,21(29),23-hexaen-7-one

(2r,8s,11s,15s,18s,22s,25s,26r)-8-benzyl-22-[(2r)-butan-2-yl]-15-[(2s)-butan-2-yl]-10,17,24-trihydroxy-26-methyl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,14(30),16,21(29),23-hexaen-7-one

C36H49N7O5S2 (723.3236)


   

(2s,8r,11r,15s,18r,22s,25s,26r)-8-benzyl-22-[(2r)-butan-2-yl]-15-[(2s)-butan-2-yl]-10,17,24-trihydroxy-26-methyl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,14(30),16,21(29),23-hexaen-7-one

(2s,8r,11r,15s,18r,22s,25s,26r)-8-benzyl-22-[(2r)-butan-2-yl]-15-[(2s)-butan-2-yl]-10,17,24-trihydroxy-26-methyl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,14(30),16,21(29),23-hexaen-7-one

C36H49N7O5S2 (723.3236)


   

(2s,8r,11r,15s,18r,22s,25s,26r)-8-benzyl-10,17,24-trihydroxy-26-methyl-15,22-bis(sec-butyl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,14(30),16,21(29),23-hexaen-7-one

(2s,8r,11r,15s,18r,22s,25s,26r)-8-benzyl-10,17,24-trihydroxy-26-methyl-15,22-bis(sec-butyl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,14(30),16,21(29),23-hexaen-7-one

C36H49N7O5S2 (723.3236)